ONCOLife presents an exclusive interview with Dr. Miguel-Angel Perales, Co-Chair of the CAR T Vision initiative, as he shares ...

We’re honored to share our exclusive interview with Lorna Warick, CEO of Lymphoma Coalition. In this session, we explore the ...

About ONCOLife ONCOLife as a cutting-edge oncology magazine designed for oncologists and health professionals. It has flexible format, available both in print and online formats in the US and EU, ...

Health and Pharma is a pioneering news and communications platform focused on health science, biotechnology, and pharmaceutical developments.

ONCOLife as a cutting-edge oncology magazine designed for oncologists and health professionals. It has flexible format, available both in print and online formats in the US and EU, ONCOLife is ...

We are pleased to present an exclusive interview with Dana Brown, CEO and Chairman of the Board at iCAD Inc., to explore the future of breast cancer screening and the role of artificial intelligence ...

Nick Slack shares strategic insights on expanding global access to early- and late-phase cancer trials, the development of patient-derived xenograft (PDX) models, and the creation of a robust ...

With BAY 3547926, Bayer adds a third targeted alpha therapy (TAT) to its clinical pipeline, joining 225Ac-Pelgifatamab and 225Ac-PSMA-Trillium—both under investigation for metastatic ...

The South Korean biopharmaceutical company Rznomics Inc. has announced that its novel RNA-based therapy, RZ-001, designed for the treatment of Hepatocellular Carcinoma (HCC), has been granted Orphan ...

A Canadian Cancer Society-funded trial shows a 3-year structured exercise program post-chemotherapy improves survival for colon cancer patients. Involving 889 participants, the trial saw a 28% ...